title: Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation--effect of crosslinking.
abstract: Two experiments were performed to assess viral inactivation during the crosslinking and heat treatment steps of the DCLHb manufacturing process. Stroma free hemoglobin (SFHb) collected from a large scale manufacturing lot was tested in a 1:680 scaled down system in which the key parameters used in the manufacturing process were replicated. In the first study Porcine Parvovirus (PPV), a non-enveloped virus, was used to assess inactivation, while in the second study Bovine Viral Diarrhea Virus (BVDV), an enveloped virus, was utilized. In both experiments, the SFHb solution was deoxygenated and an aliquot of virus suspension was added. To initiate the crosslinking reaction, a solution of bis (3,5-dibromosalicyl) fumarate (DBBF) in HEPES buffer was added to the test solution. In both experiments the reaction times and the degree of crosslinking were normal. After crosslinking, the reaction mixtures were heated to 74 +/- 1 degrees C over 30 minutes, held at 74 +/- 1 degrees C for 90 minutes, and cooled to less than 10 degrees C over 30 minutes. In each experiment the degree of crosslinking of final product was 100% and yield of hemoglobin recovery was normal. Samples were removed prior to crosslinking, after crosslinking and before, during and after heat treatment for determination of virus titer and evaluation of key process parameters. The results from these experiments were consistent with those obtained from the full scale manufacturing process for the deoxygenation, crosslinking and the heat treatment step during the production of DCLHb. The results of virus assays showed that crosslinking has no effect on viruses and their subsequent inactivation by heat treatment.
authors.affiliation: Blood Substitutes Program, Baxter Healthcare Corporation, Round Lake, Illinois 60073, USA.
authors.forename: M
authors.initials: M
authors.lastname: Azari
authors.forename: J
authors.initials: J
authors.lastname: Catarello
authors.forename: K
authors.initials: K
authors.lastname: Burhop
authors.forename: T
authors.initials: T
authors.lastname: Camacho
authors.forename: A
authors.initials: A
authors.lastname: Ebeling
authors.forename: T
authors.initials: T
authors.lastname: Estep
authors.forename: S
authors.initials: S
authors.lastname: Guzder
authors.forename: K
authors.initials: K
authors.lastname: Krause
authors.forename: T
authors.initials: T
authors.lastname: Marshall
authors.forename: K
authors.initials: K
authors.lastname: Rohn
authors.forename: R
authors.initials: R
authors.lastname: Sarajari
authors.forename: J A
authors.initials: JA
authors.lastname: Boose
authors.forename: G
authors.initials: G
authors.lastname: Gauvin
authors.forename: R
authors.initials: R
authors.lastname: Horner
authors.forename: B
authors.initials: B
authors.lastname: Lu
authors.forename: L
authors.initials: L
authors.lastname: Pearson
authors.forename: D
authors.initials: D
authors.lastname: Vacante
mesh_terms: D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives* / Q000378:metabolism; D002417:Cattle; D003432:Cross-Linking Reagents / Q000378:metabolism*; D001908:Diarrhea Viruses, Bovine Viral / Q000254:growth & development*; D006454:Hemoglobins / Q000378:metabolism*; D006358:Hot Temperature; D017992:Parvovirus / Q000254:growth & development*; D013552:Swine; D010948:Viral Plaque Assay
chemical_list: D003432:Cross-Linking Reagents; D006454:Hemoglobins; C083478:diaspirin-cross-linked hemoglobin; D001241:Aspirin